Pursuant to the provisions of Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Everest Organics has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, the 25th day of June, 2020 at 11:30 am, at the Corporate Office of the Company at Hyderabad to consider and approve Audited Financial Results of the Company for the fourth quarter and financial year ended March 31, 2020, and to consider recommendation of dividend for the financial year ended March 31,2020 subject to the approval of shareholders at the ensuing Annual General Meeting. Further, pursuant to the Company's Code of Conduct to Regulate, Monitor and Report share trading by Designated Persons, the trading window closure for dealing in the securities of the Company commenced on April 1, 2020 and shall re-open after 48 hours of the declaration of financial results of the Company, ie. on June 27,2020.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: